ReachMD
Be part of the knowledge.™Public Profile
Affiliations Disclosures
Ms. Close has ongoing business relationships with the following companies: Abbott, Amylin, Alkermes, Baxter, Bayer, Becton Dickinson, Biocon, Biodel, Calibra, DexCom, Diabetes America, Enject, Eli Lilly, Insulet, InteKrin, Intuity Medical, J&J, Marcadia, Medtronic, Merck, MicroCHIPs, Novartis, Novo Nordisk, Pfizer, Proteus Biomedical, Roche, Sanofi-aventis, Tandem Diabetes, Tolerx, Unomedical, Valeritas, and Vivus.
Kelly L. Close is president of Close Concerns, Inc., a healthcare information firm exclusively focused on the business of diabetes. Close Concerns publishes Diabetes Close Up, a monthly industry newsletter and Closer Look, a real-time news service covering all goings-on in diabetes. Kelly is also editor-in-chief of diaTribe, a free online newsletter focused on new research and products for people with diabetes (diaTribe.us). She and her colleagues attend over 30 conferences globally focused on diabetes, cover all key medical literature in the field, and keep up with over 60 private and public companies. Kelly's passion for the field comes from her extensive professional work as well as her personal experience as a patient with type 1 diabetes for over 20 years. Her analytic expertise come from nearly ten years researching medical technology as an equity research analyst; prior to this, Kelly worked at McKinsey & Company, focused on the healthcare practice. Kelly is a graduate of Amherst College and Harvard Business School. A longtime diabetes advocate, Kelly is on advisory boards for the Bay Area JDRF, dLife, the Children with Diabetes Foundation, and the Diabetes Hands Foundation.